Last reviewed · How we verify
Mycophenolate Mofetil Capsules
Mycophenolate Mofetil Capsules is a Small molecule drug developed by First Affiliated Hospital Xi'an Jiaotong University. It is currently FDA-approved. Also known as: Other MPAs.
Mycophenolate Mofetil Capsules are used to treat various conditions, including renal and liver transplantation rejection, and have been studied for their effects on psychological stress, hypertension, and chronic myeloproliferative disorders. They work by inhibiting the enzyme inosine-5'-monophosphate dehydrogenase (IMPDH), which is involved in the production of guanine nucleotides.
At a glance
| Generic name | Mycophenolate Mofetil Capsules |
|---|---|
| Also known as | Other MPAs |
| Sponsor | First Affiliated Hospital Xi'an Jiaotong University |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- A Study to Investigate the Efficacy and Safety of Frexalimab Versus Tacrolimus in Adults Undergoing Kidney Transplantation (PHASE2, PHASE3)
- Study to Compare the Efficacy and Safety After Conversion to RaparoBell® or My-Rept® in Kidney Transplant Patients (PHASE4)
- Long-Term Voclosporin Treatment in Adolescent and Pediatric Subjects With Lupus Nephritis (PHASE3)
- Optimizing PTCy Dose and Timing (PHASE1, PHASE2)
- Pulse Wave Velocity, Tacrolimus Time in Therapeutic Range and CV in African American Kidney Transplants (PHASE4)
- Examining Distinct Immunophenotypes to Validate and Enhance Rational Treatment in Systemic Lupus (PHASE2)
- Mycophenolate Mofetil in Patients With Progressive Idiopathic Membranous Nephropathy (PHASE3)
- Mycophenolate Mofetil Combined With Radiation Therapy in Glioblastoma (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Mycophenolate Mofetil Capsules CI brief — competitive landscape report
- Mycophenolate Mofetil Capsules updates RSS · CI watch RSS
- First Affiliated Hospital Xi'an Jiaotong University portfolio CI
Frequently asked questions about Mycophenolate Mofetil Capsules
What is Mycophenolate Mofetil Capsules?
Who makes Mycophenolate Mofetil Capsules?
Is Mycophenolate Mofetil Capsules also known as anything else?
What development phase is Mycophenolate Mofetil Capsules in?
Related
- Manufacturer: First Affiliated Hospital Xi'an Jiaotong University — full pipeline
- Also known as: Other MPAs
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing